Medication-overuse headache: a review

被引:45
作者
Kristoffersen, Espen Saxhaug [1 ,2 ,3 ]
Lundqvist, Christofer [1 ,2 ,4 ]
机构
[1] Akershus Univ Hosp, Res Ctr, Lorenskog, Norway
[2] Akershus Univ Hosp, Dept Neurol, Nordbyhagen, Norway
[3] Univ Oslo, Inst Hlth & Soc, Dept Gen Practice, N-0318 Oslo, Norway
[4] Univ Oslo, Campus Akershus Univ Hosp, Inst Clin Med, Nordbyhagen, Norway
关键词
medication-overuse headache; migraine; chronic headache; dependence; STRUCTURED DETOXIFICATION PROGRAMS; CHRONIC FREQUENT HEADACHE; CHRONIC MIGRAINE PATIENTS; PLACEBO-CONTROLLED PHASE; POPULATION-BASED SAMPLE; GENERAL-POPULATION; ANALGESIC-OVERUSE; FOLLOW-UP; CLINICAL-FEATURES; DOUBLE-BLIND;
D O I
10.2147/JPR.S46071
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Medication-overuse headache (MOH) is a worldwide health problem with a prevalence of 1%-2%. It is a severe form of headache where the patients often have a long history of headache and of unsuccessful treatments. MOH is characterized by chronic headache and overuse of different headache medications. Through the years, withdrawal of the overused medication has been recognized as the treatment of choice. However, currently, there is no clear consensus regarding the optimal strategy for management of MOH. Treatment approaches are based on expert opinion rather than scientific evidence. This review focuses on aspects of epidemiology, diagnosis, pathogenesis, prevention, and treatment of MOH. We suggest that information and education about the risk of MOH is important since the condition is preventable. Most patients experience reduction of headache days and intensity after successful treatment. The first step in the treatment of MOH should be carried out in primary care and focus primarily on withdrawal, leaving prophylactic medication to those who do not manage primary detoxification. For most patients, a general practitioner can perform the follow-up after detoxification. More complicated cases should be referred to neurologists and headache clinics. Patients suffering with MOH have much to gain by an earlier treatment-focused approach, since the condition is both preventable and treatable.
引用
收藏
页码:367 / 378
页数:12
相关论文
共 167 条
[1]   Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons.: The Akershus study of chronic headache [J].
Aaseth, K. ;
Grande, R. B. ;
Kvaerner, K. J. ;
Gulbrandsen, P. ;
Lundqvist, C. ;
Russell, M. B. .
CEPHALALGIA, 2008, 28 (07) :705-713
[2]  
Abbott FV, 1998, J PSYCHIATR NEUROSCI, V23, P13
[3]   Disability in chronic migraine with medication overuse: Treatment effects through 5 years [J].
Andrasik, F. ;
Grazzi, L. ;
Usai, S. ;
Kass, S. ;
Bussone, G. .
CEPHALALGIA, 2010, 30 (05) :610-614
[4]  
[Anonymous], 1962, JAMA-J AM MED ASSOC, V179, P717
[5]   Prescription and nonprescription analgesic use in Sweden [J].
Antonov, KIM ;
Isacson, DGL .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (04) :485-494
[6]   Low income and education levels may cause medication overuse and chronicity in migraine patients [J].
Atasoy, HT ;
Unal, AE ;
Atasoy, N ;
Emre, U ;
Sumer, M .
HEADACHE, 2005, 45 (01) :25-31
[7]  
Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676
[8]   Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures [J].
Ayzenberg, I. ;
Obermann, M. ;
Nyhuis, P. ;
Gastpar, M. ;
Limmroth, V. ;
Diener, H. C. ;
Kaube, H. ;
Katsarava, Z. .
CEPHALALGIA, 2006, 26 (09) :1106-1114
[9]   Does chronic daily headache arise de novo in association with regular use of analgesics? [J].
Bahra, A ;
Walsh, M ;
Menon, S ;
Goadsby, PJ .
HEADACHE, 2003, 43 (03) :179-190
[10]   Drug-associated headache is unrecognized in patients treated at a neurological centre [J].
Bekkelund, SI ;
Salvesen, R .
ACTA NEUROLOGICA SCANDINAVICA, 2002, 105 (02) :120-123